Baranzate, Italy

Niccolo′ Santillo

This inventor holds 1 USPTO granted patent. Top assignee: Dipharma Francis S.r.l.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niccolo′ Santillo. Retrieved from https://idiyas.com/inventor/niccolo′-santillo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Niccolo′ Santillo: Innovator in Topical Anti-Inflammatory Agents

Introduction

Niccolo′ Santillo is a notable inventor based in Baranzate, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical anti-inflammatory agents. His innovative work has led to the creation of a unique process that enhances the efficacy of these agents.

Latest Patents

Niccolo′ Santillo holds 1 patent for his invention titled "Intermediates and process for the preparation of a crystalline form of a topical anti-inflammatory agent." This patent focuses on a process for preparing an inhibitor of phosphodiesterase 4, specifically phosphodiesterase 4B (PDE4B), along with the intermediates that are useful for its preparation.

Career Highlights

Santillo is currently associated with Dipharma Francis S.r.l., where he continues to work on innovative pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset to the company and the industry at large.

Collaborations

Throughout his career, Niccolo′ Santillo has collaborated with talented individuals such as Emanuele Attolino and Davide Brenna. These partnerships have fostered a creative environment that encourages the development of groundbreaking inventions.

Conclusion

Niccolo′ Santillo's contributions to the pharmaceutical industry exemplify the impact of innovation in healthcare. His work on topical anti-inflammatory agents showcases the importance of research and development in improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…